Related references
Note: Only part of the references are listed.Bile acid abnormality induced by intestinal dysbiosis might explain lipid metabolism in Parkinson's disease
Yuhei Hasuike et al.
MEDICAL HYPOTHESES (2020)
Altered body composition, sarcopenia, frailty, and their clinico-biological correlates, in Parkinson's disease
Ai Huey Tan et al.
PARKINSONISM & RELATED DISORDERS (2018)
A Role for Neuronal Alpha-Synuclein in Gastrointestinal Immunity
Ethan Stolzenberg et al.
JOURNAL OF INNATE IMMUNITY (2017)
Utility of the wireless motility capsule and lactulose breath testing in the evaluation of patients with Parkinson's disease who present with functional gastrointestinal symptoms
Andrew Su et al.
BMJ OPEN GASTROENTEROLOGY (2017)
Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis
Xin Fang
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2016)
Prevalence of small intestinal bacterial overgrowth in Chinese patients with Parkinson's disease
Xiao-Lu Niu et al.
JOURNAL OF NEURAL TRANSMISSION (2016)
Brain-gut-microbiota axis in Parkinson's disease
Agata Mulak et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Gut Microbiota Are Related to Parkinson's Disease and Clinical Phenotype
Filip Scheperjans et al.
MOVEMENT DISORDERS (2015)
Delayed Gastric Emptying in Parkinson's Disease
Sarah Marrinan et al.
MOVEMENT DISORDERS (2014)
Progression of Intestinal Permeability Changes and Alpha-Synuclein Expression in a Mouse Model of Parkinson's Disease
Leo P. Kelly et al.
MOVEMENT DISORDERS (2014)
Small intestinal bacterial overgrowth in Parkinson's disease
Ai Huey Tan et al.
PARKINSONISM & RELATED DISORDERS (2014)
Osteoporosis risk and bone mineral density levels in patients with Parkinson's disease: A meta-analysis
Yan Zhao et al.
BONE (2013)
Antimicrobial Surveillance in Idiopathic Parkinsonism: Indication-Specific Improvement in Hypokinesia Following Helicobacter pylori Eradication and Non-Specific Effect of Antimicrobials for Other Indications in Worsening Rigidity
Sylvia M. Dobbs et al.
HELICOBACTER (2013)
Bone mineral density and vitamin D status in Parkinson's disease patients
F. van den Bos et al.
JOURNAL OF NEUROLOGY (2013)
The role of small intestinal bacterial overgrowth in Parkinson's disease
Alfonso Fasano et al.
MOVEMENT DISORDERS (2013)
Plasma levodopa peak delay and impaired gastric emptying in Parkinson's disease
Hirokazu Doi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Leukocyte-subset counts in idiopathic parkinsonism provide clues to a pathogenic pathway involving small intestinal bacterial overgrowth. A surveillance study
R. John Dobbs et al.
GUT PATHOGENS (2012)
Cell-based therapies for Parkinson's disease
Sean C. Dyson et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2011)
Prevalence of Small Intestinal Bacterial Overgrowth in Parkinson's Disease
Maurizio Gabrielli et al.
MOVEMENT DISORDERS (2011)
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Non-Motor Symptoms of Parkinson's Disease
Klaus Seppi et al.
MOVEMENT DISORDERS (2011)
How to Interpret Hydrogen Breath Tests
Uday C. Ghoshal
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2011)
Methodology and Indications of H2-Breath Testing in Gastrointestinal Diseases: the Rome Consensus Conference
A. Gasbarrini et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Blood profile holds clues to role of infection in a premonitory state for idiopathic parkinsonism and of gastrointestinal infection in established disease
Andre Charlett et al.
GUT PATHOGENS (2009)
Share Paper
